NCT Number: NCT02512354
Contribution of High-throughput Exome Sequencing in the Diagnosis of the Cause Fetal Polymalformation Syndromes
This research concerns the contribution of a new examination, high-throughput exome sequencing, in the diagnosis of the cause of polymalformative fetal syndromes. With currently available examinations, the causes of polyformative syndromes, which correspond to the association of several congenital malformations with varying degrees of severity in different organs, remain unknown in a large number of cases.
High-throughput exome sequencing (HTES) is a diagnostic tool that allows the simultaneous analysis of all of the coding parts of DNA. This examination has already shown its superior diagnostic capability in every post-natal diagnostic context, in particulier in infants with malformations associated or not with intellectual deficiency. Its contribution has not yet been studied in a large number of fetuses with polymalformations. To investigate the usefulness of HTES, we propose to carry out the examination in 100 fetuses with polymalformations, as well as the usual examinations including chromosomal microarray analysis and possibly the study of specific genes that may explain these malformations. A blood sample will be taken from both parents to allow interpretation of the results.
Looking for future studies?
Notify MeKey information
Sex eligibility
All sexes
Study type
Observational
Primary location
CHU de Clermont-Ferrand, Clermont-Ferrand, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Fetus with at least 2 malformations, with no diagnosis (or several low-certainty diagnostic hypotheses, which require several molecular examinations) after fetopathological and radiological examinations
- Written consent from both parents
- Possibility to obtain samples from both parents
Exclusion criteria
- Refusal of parents to take part in the study
- Parents without National Health Insurance cover
- Parents under guardianship or in custody
- Impossibility to obtain samples from both parents
- Diagnostic hypothesis considered highly probable for which a molecular test cheaper that HTES is available
Treatment and study plan
Parent's blood samples
OtherPrimary outcomes
-
Number of additional diagnoses made thanks to HTES compared with the usual examinations
Time frame: baseline
-
Number of diagnoses not made by HTES compared with usual examinations
Time frame: baseline
Sponsors and collaborators
Lead sponsor
Centre Hospitalier Universitaire Dijon
Other
Registry information
Official study title
Contribution of High-throughput Exome Sequencing in Fetopathology
Acronym: FOETEX
Important dates
- Study start
- 2015
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Jul 30, 2015
- Registry last updated
- Feb 9, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.